糖皮质激素治疗早、中期肝衰竭临床疗效观察  

The Effect of Glucocorticoid in the Treatment of Patients with Hepatic Failure

作　　者：陈国春[1] 童学成[1] 巢为农[2] 

机构地区：[1]常州市第三人民医院感染科,江苏常州213001 [2]常州市武进区奔牛人民医院,江苏常州213131

出　　处：《中国血液流变学杂志》2010年第4期600-601,615,共3页Chinese Journal of Hemorheology

摘　　要：目的 观察糖皮质激素治疗早、中期肝衰竭的疗效.方法 62例肝衰竭早、中期患者随机分为内科治疗组（对照组）和激素治疗组（治疗组）,对照组采用保肝、退黄、支持等治疗,治疗组在此基础上加用氧化可的松琥珀酸钠,观察患者临床症状,生化学指标及激素不良反应.结果 治疗组好转率明显高于对照组,激素治疗没有增加患者严重不良反应发生率.结论 小剂量糖皮质激素对早、中期肝衰竭患者具有良好效果,且不良反应较少,可明显提高存活率.Objective To explore the effect ofglucocorticoid in the treatment of patients with hepatic failure. Methods 62 patients with hepatic failure were selected and 29 patients received treatment of glucocorticoid at base of conventional treatment,other 33 received conventional therapy. Result The levels of the ALB,CHO and PTA in treatment group were higher than in control group. Conclusion Glucocorticoid in the treatment of patients with hepatic failure can effectively decrease the mortality rate.

关 键 词：肝衰竭 糖皮质激素 治疗 

分 类 号：R575.3[医药卫生—消化系统]